Zura Bio Ltd SEC filings ZURA
Zura Bio Ltd has 446 filings in SEC EDGAR's recent list, going back to Apr 8, 2021. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 27, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 27, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Nov 3, 2026 | — |
| UPLOAD | Letter from the SEC | Jun 3, 2025 | — |
| CORRESP | Letter to the SEC | May 22, 2025 | — |
| UPLOAD | Letter from the SEC | May 8, 2025 | — |
| EFFECT | Filing | Sep 17, 2024 | — |
| CORRESP | Letter to the SEC | Sep 16, 2024 | — |
| EFFECT | Filing | Sep 10, 2024 | — |
| EFFECT | Filing | Sep 10, 2024 | — |
| UPLOAD | Letter from the SEC | Sep 10, 2024 | — |
| 25-NSE | Delisting notice | Aug 27, 2024 | — |
| 425 | Filing | Aug 12, 2024 | — |
| SC TO-I/A | Filing | Aug 9, 2024 | — |
| 425 | Filing | Aug 9, 2024 | — |
| EFFECT | Filing | Aug 8, 2024 | — |
| CORRESP | Letter to the SEC | Aug 6, 2024 | — |
| CORRESP | Letter to the SEC | Jul 25, 2024 | — |
| SC TO-I/A | Filing | Jul 25, 2024 | — |
| 425 | Filing | Jul 25, 2024 | — |
| UPLOAD | Letter from the SEC | Jul 19, 2024 | — |
| 425 | Filing | Jul 12, 2024 | — |
| SC TO-I | Filing | Jul 12, 2024 | — |
| EFFECT | Filing | Jun 18, 2024 | — |
| EFFECT | Filing | Jun 3, 2024 | — |
| CORRESP | Letter to the SEC | May 30, 2024 | — |
| UPLOAD | Letter from the SEC | May 29, 2024 | — |
| D | Filing | May 6, 2024 | — |
| EFFECT | Filing | Sep 14, 2023 | — |
| CORRESP | Letter to the SEC | Sep 12, 2023 | — |
| CORRESP | Letter to the SEC | Sep 8, 2023 | — |
| UPLOAD | Letter from the SEC | Sep 6, 2023 | — |
| CORRESP | Letter to the SEC | Aug 24, 2023 | — |
| UPLOAD | Letter from the SEC | Aug 17, 2023 | — |
| CORRESP | Letter to the SEC | Aug 11, 2023 | — |
| UPLOAD | Letter from the SEC | Jul 28, 2023 | — |
| CORRESP | Letter to the SEC | Jul 21, 2023 | — |
| UPLOAD | Letter from the SEC | Jun 23, 2023 | — |
| D | Filing | May 5, 2023 | — |
| CERT | Filing | Mar 21, 2023 | — |
| 25 | Form 25 | Mar 20, 2023 | — |
| 8-A12B | Filing | Mar 20, 2023 | — |
| 425 | Filing | Mar 16, 2023 | — |
| 425 | Filing | Mar 15, 2023 | — |
| 425 | Filing | Mar 10, 2023 | — |
| 425 | Filing | Mar 2, 2023 | — |
| SEC STAFF LETTER | Filing | Feb 28, 2023 | — |
| EFFECT | Filing | Feb 28, 2023 | — |
| CORRESP | Letter to the SEC | Feb 24, 2023 | — |
| CORRESP | Letter to the SEC | Feb 22, 2023 | — |
| UPLOAD | Letter from the SEC | Feb 22, 2023 | — |
| CORRESP | Letter to the SEC | Feb 17, 2023 | — |
| SEC STAFF LETTER | Filing | Feb 14, 2023 | — |
| CORRESP | Letter to the SEC | Feb 10, 2023 | — |
| CORRESP | Letter to the SEC | Feb 2, 2023 | — |
| UPLOAD | Letter from the SEC | Jan 20, 2023 | — |
| 425 | Filing | Jan 19, 2023 | — |
| CORRESP | Letter to the SEC | Jan 9, 2023 | — |
| UPLOAD | Letter from the SEC | Dec 27, 2022 | — |
| CORRESP | Letter to the SEC | Dec 19, 2022 | — |
| 425 | Filing | Dec 12, 2022 | — |
| DEFR14A | Filing | Dec 7, 2022 | — |
| 425 | Filing | Nov 15, 2022 | — |
| UPLOAD | Letter from the SEC | Nov 4, 2022 | — |
| CORRESP | Letter to the SEC | Oct 25, 2022 | — |
| UPLOAD | Letter from the SEC | Oct 4, 2022 | — |
| CORRESP | Letter to the SEC | Sep 20, 2022 | — |
| UPLOAD | Letter from the SEC | Sep 2, 2022 | — |
| 425 | Filing | Aug 30, 2022 | — |
| CORRESP | Letter to the SEC | Aug 19, 2022 | — |
| UPLOAD | Letter from the SEC | Aug 3, 2022 | — |
| DRS | Filing | Jul 6, 2022 | — |
| 425 | Filing | Jun 17, 2022 | — |
| NT 10-K | Form nt 10-k | Mar 31, 2022 | Dec 31, 2021 |
| NT 10-Q | Filing | Nov 15, 2021 | Sep 30, 2021 |
| EFFECT | Filing | Jul 13, 2021 | — |
| CERT | Nyse certification | Jul 13, 2021 | — |
| 8-A12B | Filing | Jul 13, 2021 | — |
| CORRESP | Letter to the SEC | Jul 8, 2021 | — |
| CORRESP | Letter to the SEC | Jul 8, 2021 | — |
| CORRESP | Letter to the SEC | Jun 15, 2021 | — |
| UPLOAD | Letter from the SEC | May 5, 2021 | — |
| DRS | Filing | Apr 8, 2021 | — |
Showing 81 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- ZURA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Cayman Islands
- Headquarters
- La Jolla, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1855644
- Former names
- JATT Acquisition Corp (until Mar 21, 2023)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.